Criterion #,Criterion,Max Score,Satisfaction (%),Score Awarded,Rationale
1,"Reward for documenting verbatim or clearly paraphrased patient reports of (a) improved blood sugars, (b) increased thirst as a side-effect, and (c) difficulty remembering morning empagliflozin dose because of irregular driving schedule, without adding unspoken details.",20,10.0,2.0,"Patient narrative details (better sugars, thirst side-effect, difficulty remembering morning dose) are entirely absent; only instructions are documented."
2,"Reward for recording counseling given: specific hydration advice and a concrete adherence aid (e.g., phone alarm/app) that matches the dialogue.",15,90.0,13.5,Note includes both hydration advice and a concrete reminder tool exactly as discussed.
3,"Reward for including an evidence-based assessment & plan for type 2 diabetes that references current SGLT2 + metformin therapy and indicates follow-up monitoring (e.g., A1c or weight check).",15,0.0,0.0,"No assessment or plan for T2DM, no reference to current SGLT2+metformin therapy, and no follow-up labs documented."
4,Reward for explicitly noting the social determinant that the patient’s irregular work/travel schedule impairs medication adherence.,5,0.0,0.0,Irregular work/travel schedule affecting adherence is not explicitly mentioned.
5,"Penalize for failure to list or reconcile both current antidiabetic medications (metformin 1000 mg, empagliflozin 10 mg) in the documentation.",5,0.0,0.0,Neither metformin nor empagliflozin are listed or reconciled.
6,"Penalize for inclusion of fabricated, speculative, or duplicated information that is not supported by the transcript or chart (e.g., inventing weight-gain data, lab values, or allergy status).",25,100.0,25.0,No fabricated or speculative information is present; only verifiable counseling statements.
7,"Reward for correct use of appropriate Canvas structured commands (e.g., HistoryOfPresentIllness, Instruct, Assess) to capture this segment’s content without unnecessary duplication.",10,80.0,8.0,"Commands used are valid Instruct commands without duplication, but other appropriate sections (HPI, Assess) are missing."
8,"Penalize for missing or insufficient safety documentation regarding SGLT2-inhibitor risks (dehydration, DKA/UTI signs) and when to seek care.",25,20.0,5.0,Safety counseling on DKA/UTI signs and when to seek care is largely missing; only generic hydration advice given.
